D. Ulanet

发表

Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase.

Christer S. Ejsing, D. Hanahan, J. Nylandsted, 2013, Cancer cell.

Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia

L. Kats, R. Johnstone, K. Stanley, 2022, EMBO molecular medicine.

Autoantibodies against B23, a nucleolar phosphoprotein, occur in scleroderma and are associated with pulmonary hypertension.

A. Gelber, A. Rosen, F. Wigley, 2003, Arthritis and rheumatism.

Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH.

Yaguang Si, S. Choe, Giovanni Cianchetta, 2016, Cell reports.

Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status

A. Rosen, L. Casciola-Rosen, D. Ulanet, 1999, The Journal of experimental medicine.

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

Douglas Hanahan, D. Hanahan, C. Kahn, 2010, Proceedings of the National Academy of Sciences.

Loss of p19Arf Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms

Douglas Hanahan, D. Hanahan, Danielle B. Ulanet, 2010, PloS one.

Genetic Ablation of Bcl-x Attenuates Invasiveness without Affecting Apoptosis or Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Cancer

D. Hanahan, L. Hennighausen, J. Hager, 2009, PloS one.

Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition

Abhishek K. Jha, S. Choe, S. Gross, 2014, Cancer & Metabolism.

Selective cleavage of nucleolar autoantigen B23 by granzyme B in differentiated vascular smooth muscle cells: insights into the association of specific autoantibodies with distinct disease phenotypes.

Livia Casciola-Rosen, N. Flavahan, A. Rosen, 2004, Arthritis and rheumatism.

Unique conformation of cancer autoantigen B23 in hepatoma: A mechanism for specificity in the autoimmune response

C. Dang, M. Torbenson, A. Rosen, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of pyrimidine biosynthesis targets protein translation in AML

L. Kats, R. Johnstone, K. Stanley, 2021, bioRxiv.

Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate Dehydrogenase

G. Lenz, S. Choe, K. Marks, 2020, Molecular Cancer Therapeutics.

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

J. Reis-Filho, R. Plummer, F. Meric-Bernstam, 2023, Nature Medicine.

Abstract CT030: Genomic and pathologic determinants of response to RP-3500, an ataxia telangiectasia and Rad3-related inhibitor (ATRi), in patients (pts) with DNA damage repair (DDR) loss-of-function (LOF) mutant tumors in the Phase 1/2 TRESR trial

J. Reis-Filho, R. Plummer, S. Lheureux, 2022, Cancer Research.

Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibition

Abhishek K. Jha, S. Choe, S. Gross, 2014, Cancer & Metabolism.

5MO Comprehensive dose-finding strategy for single-agent RP-3500, a highly selective inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase

R. Plummer, M. Koehler, S. Lheureux, 2022, Annals of Oncology.

Inaugural Article: Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

D. Hanahan, D. Ludwig, D. Ulanet, 2010 .